海正药业(600267.SH)子公司获得兽药产品批准文号批件

Core Viewpoint - Haizheng Pharmaceutical (600267.SH) has received approval from the Ministry of Agriculture and Rural Affairs of the People's Republic of China for its veterinary drug products, which will enhance its product line and market competitiveness in the veterinary sector [1] Group 1 - Haizheng Pharmaceutical's subsidiary, Zhejiang Haizheng Animal Health Products Co., Ltd., has obtained approval for the compound griseofulvin ointment and torasemide suspension veterinary drug products [1] - The approval will enrich the company's veterinary drug product line and structure [1] - This development is expected to further promote the company's strategic layout in the veterinary drug sector [1]